FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2128757024> ?p ?o ?g. }

• W2128757024 endingPage "6" @default.
• W2128757024 startingPage "1271" @default.
• W2128757024 abstract "The prothrombin G20210A mutation and factor V Leiden have been found to be associated with an increased risk of venous thrombosis, but the reported prevalences of the prothrombin gene variant both in the normal population and in patients with deep venous thrombosis (DVT) vary greatly in the literature. Moreover, the influence of oral contraceptives (OC) on thrombotic events in patients with the prothrombin G20210A variant has not been well established. In this study we evaluate both circumstances.A case-control study was run on 229 patients with DVT and 246 healthy controls. The patients' history of thrombosis and acquired thrombotic risk factors, especially OC, were recorded. Prothrombin G20210A mutation, factor V Leiden, antithrombin, heparin II cofactor, plasminogen and proteins C and S were evaluated.Seven and a half percent of the patients and 2.9% of the controls were carriers of the prothrombin mutation, while 12.2% of the patients and 1.6% of the controls had factor V Leiden. Among the 229 DVT patients there were 130 patients with clinically suspected thrombophilia (first thrombotic event occurring before the age of 45 years or positive family history of thrombosis or recurrent venous thrombosis). Ten percent of these 130 patients were carriers of the prothrombin G20210A mutation and 18.5% had the factor V Leiden mutation. The odds ratios (OR) for DVT risk were: 2.4 (95% CI, 1.0-6.3) for the total DVT patients and 5.2 (95% CI, 1.4-19.5) for the patients with clinically suspected thrombophilia with the prothrombin mutation. The risk of thrombosis was 6.9 (95% CI, 2.3-20.6) for the DVT patients and 14.3 (95% CI, 3.3-64.6) for the patients with clinically suspected thrombophilia with factor V Leiden. Fifty-five percent of the patients with combined congenital defects (prothrombin mutation G20210A plus another congenital defect) had recurrent thrombosis. In women receiving OC the risk of DVT was 3.5 (95% CI, 1.5-8.2) that of the patients not receiving OC. When women with combined defects were also taking OC, the risk of thrombosis increased significantly.The prevalence of the prothrombin G20210A mutation in the healthy population in our study is similar to that observed in other southern European countries. The prothrombin G20210A mutation does not by itself seem to be a high thrombotic risk factor. However, when it is present together with other thrombotic risk factors, the predicted risk of thrombotic events increases. The use of OC by women with the prothrombin G20210A variant or FV Leiden, either alone or combined with other thrombotic risk factors, was associated with a significant increase in the risk of venous thrombosis." @default.
• W2128757024 created "2016-06-24" @default.
• W2128757024 creator A5021978850 @default.
• W2128757024 creator A5026232495 @default.
• W2128757024 creator A5029943902 @default.
• W2128757024 creator A5038247490 @default.
• W2128757024 creator A5041628487 @default.
• W2128757024 creator A5057986151 @default.
• W2128757024 creator A5068695724 @default.
• W2128757024 creator A5075235331 @default.
• W2128757024 creator A5079018683 @default.
• W2128757024 creator A5089948152 @default.
• W2128757024 date "2000-12-01" @default.
• W2128757024 modified "2023-10-11" @default.
• W2128757024 title "Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives." @default.
• W2128757024 cites W1531281563 @default.
• W2128757024 cites W1560801910 @default.
• W2128757024 cites W159656921 @default.
• W2128757024 cites W1687914218 @default.
• W2128757024 cites W1885843860 @default.
• W2128757024 cites W1950876602 @default.
• W2128757024 cites W1969138367 @default.
• W2128757024 cites W1982931872 @default.
• W2128757024 cites W1992127247 @default.
• W2128757024 cites W2013155340 @default.
• W2128757024 cites W2027305675 @default.
• W2128757024 cites W2038526384 @default.
• W2128757024 cites W2045975961 @default.
• W2128757024 cites W2049731767 @default.
• W2128757024 cites W2097276579 @default.
• W2128757024 cites W2115885282 @default.
• W2128757024 cites W2127184918 @default.
• W2128757024 cites W2128000186 @default.
• W2128757024 cites W2130036963 @default.
• W2128757024 cites W2146226041 @default.
• W2128757024 cites W2157876594 @default.
• W2128757024 cites W2163474339 @default.
• W2128757024 cites W2208279710 @default.
• W2128757024 cites W2210739182 @default.
• W2128757024 cites W2318577668 @default.
• W2128757024 cites W2410590026 @default.
• W2128757024 cites W2428232843 @default.
• W2128757024 cites W2443527059 @default.
• W2128757024 cites W2462261788 @default.
• W2128757024 cites W2793671163 @default.
• W2128757024 cites W305173082 @default.
• W2128757024 cites W92365771 @default.
• W2128757024 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11114134" @default.
• W2128757024 hasPublicationYear "2000" @default.
• W2128757024 type Work @default.
• W2128757024 sameAs 2128757024 @default.
• W2128757024 citedByCount "37" @default.
• W2128757024 countsByYear W21287570242012 @default.
• W2128757024 countsByYear W21287570242013 @default.
• W2128757024 countsByYear W21287570242014 @default.
• W2128757024 countsByYear W21287570242016 @default.
• W2128757024 countsByYear W21287570242018 @default.
• W2128757024 countsByYear W21287570242019 @default.
• W2128757024 crossrefType "journal-article" @default.
• W2128757024 hasAuthorship W2128757024A5021978850 @default.
• W2128757024 hasAuthorship W2128757024A5026232495 @default.
• W2128757024 hasAuthorship W2128757024A5029943902 @default.
• W2128757024 hasAuthorship W2128757024A5038247490 @default.
• W2128757024 hasAuthorship W2128757024A5041628487 @default.
• W2128757024 hasAuthorship W2128757024A5057986151 @default.
• W2128757024 hasAuthorship W2128757024A5068695724 @default.
• W2128757024 hasAuthorship W2128757024A5075235331 @default.
• W2128757024 hasAuthorship W2128757024A5079018683 @default.
• W2128757024 hasAuthorship W2128757024A5089948152 @default.
• W2128757024 hasConcept C126322002 @default.
• W2128757024 hasConcept C141071460 @default.
• W2128757024 hasConcept C156957248 @default.
• W2128757024 hasConcept C2776046644 @default.
• W2128757024 hasConcept C2777175894 @default.
• W2128757024 hasConcept C2777872019 @default.
• W2128757024 hasConcept C2780011451 @default.
• W2128757024 hasConcept C2780842393 @default.
• W2128757024 hasConcept C2780868729 @default.
• W2128757024 hasConcept C2908647359 @default.
• W2128757024 hasConcept C50440223 @default.
• W2128757024 hasConcept C71924100 @default.
• W2128757024 hasConcept C90924648 @default.
• W2128757024 hasConcept C99454951 @default.
• W2128757024 hasConceptScore W2128757024C126322002 @default.
• W2128757024 hasConceptScore W2128757024C141071460 @default.
• W2128757024 hasConceptScore W2128757024C156957248 @default.
• W2128757024 hasConceptScore W2128757024C2776046644 @default.
• W2128757024 hasConceptScore W2128757024C2777175894 @default.
• W2128757024 hasConceptScore W2128757024C2777872019 @default.
• W2128757024 hasConceptScore W2128757024C2780011451 @default.
• W2128757024 hasConceptScore W2128757024C2780842393 @default.
• W2128757024 hasConceptScore W2128757024C2780868729 @default.
• W2128757024 hasConceptScore W2128757024C2908647359 @default.
• W2128757024 hasConceptScore W2128757024C50440223 @default.
• W2128757024 hasConceptScore W2128757024C71924100 @default.
• W2128757024 hasConceptScore W2128757024C90924648 @default.
• W2128757024 hasConceptScore W2128757024C99454951 @default.
• W2128757024 hasIssue "12" @default.

• next